Sirna for inhibiting expression of urate transporter 1 gene, and drug and use thereo
HK40137539APending Publication Date: 2026-09-11GUANGZHOU BEBETTER MEDICINE TECH CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- HK62026127167
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-03
- Filing Date
- 2026-08-06
- Publication Date
- 2026-09-11
Abstract
The invention discloses a siRNA (small interfering Ribonucleic Acid) for inhibiting the gene expression of a urate transporter 1 (URAT1) in a human body cell, and particularly discloses a siRNA (small interfering Ribonucleic Acid) for inhibiting the gene expression of the URAT1 in the human body cell. According to the invention, a plurality of siRNAs which can be used for inhibiting URAT1 expression are screened, and on the basis, proper modification is carried out to improve the silence ability of a target. The medicine taking the siRNA as the activity is expected to be clinically applied to prevention and treatment of diseases such as gout, hyperuricemia, gouty arthritis, kidney stone and the like related to URAT1 targets.
Need to check novelty before this filing date? Find Prior Art
